Alemtuzumab (Campath, MabCampath)

alemtuzumab · Genzyme

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alemtuzumab (Campath, MabCampath), covering 2016-07-28 to 2016-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia [Phase 3]

See pricing